News|Articles|August 1, 2025

7 Gastroenterology Headlines You Missed in July 2025

From clinical trial updates in IBD to novel research about IBS and other disorders of gut brain interaction, catch up on the latest headlines in GI.

July brought notable advances in inflammatory bowel disease (IBD) research and treatment, headlined by new findings from the GALAXI program further clarifying guselkumab’s role in Crohn’s disease (CD) management and obefazimod meeting its primary endpoint for clinical remission in 2 phase 3 trials for ulcerative colitis (UC).